Literature DB >> 5884701

Action of heparin and plasminogen inhibitor (EACA) on metastatic tumour spread in an isologous system.

B Boeryd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5884701     DOI： 10.1111/apm.1965.65.3.395

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand        ISSN： 0365-5555


× No keyword cloud information.
  8 in total

1.  Studies on the effect of methoxy-substituted glycerol ethers on tumour growth and metastasis formation.

Authors:  B Boeryd; B Hallgren; G Ställberg
Journal:  Br J Exp Pathol       Date:  1971-06

2.  Pulmonary metastasis formation after intravenous tumour cell injection in defibrinogenated rats.

Authors:  L Ivarsson
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-01-02

3.  The growth and spontaneous dissemination of melanoma B16 and Lewis lung tumour in two sub-strains of C57BL/6J mice treated with Corynebacterium parvum and/or levamisole.

Authors:  B Boeryd; A Benktson
Journal:  Clin Exp Metastasis       Date:  1983 Jul-Sep       Impact factor: 5.150

4.  The effect of thrombocytopenia and antiserotonin treatment on the lodgement of circulating tumor cells. A vital fluorescence microscopic, electron microscopic and isotope study in the rat.

Authors:  G Skolnik; L E Ericson; U Bagge
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

5.  Heparin, dextran 1000 and metastasis formation after I.V. tumour cell injection in dextran non-sensitive rats.

Authors:  L Ivarsson; C M Rudenstam
Journal:  Br J Cancer       Date:  1975-10       Impact factor: 7.640

6.  Aprotinin and growth of Walker 256 carcinosarcoma in the rat.

Authors:  A W Thomson; R G Pugh-Humphreys; C H Horne; D J Tweedle
Journal:  Br J Cancer       Date:  1977-04       Impact factor: 7.640

7.  Extrapulmonary colony formation after intravenous injection of tumour cells into heparin-treated animals.

Authors:  B Maat
Journal:  Br J Cancer       Date:  1978-03       Impact factor: 7.640

8.  Heparin regulates B6FS cell motility through a FAK/actin cytoskeleton axis.

Authors:  Kallirroi Voudouri; Dragana Nikitovic; Aikaterini Berdiaki; Dionysios J Papachristou; John Tsiaoussis; Demetrios A Spandidos; Aristides M Tsatsakis; George N Tzanakakis
Journal:  Oncol Rep       Date:  2016-08-30       Impact factor: 3.906
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.